The Effect of Panretinal Photocoagulation Treatment on Vision-Related Quality of Life of Patients with Proliferative Diabetic Retinopathy at Kariadi Hospital
Article Sidebar
-
Proliferative diabetic retinopathy, Panretinal photocoagulation, Vision-related quality of life
Abstract
Objectives: Proliferative Diabetic Retinopathy (PDR) is one of the leading causes of blindness and visual loss. Panretinal Photocoagulation (PRP) reduces the risk of severe vision loss in PDR. Good visual acuity results can improve vision-related quality of life. The objective of this study is to evaluate the effect of laser PRP on patients with PDR on vision-related quality of life.
Methods: In this prospective study, 30 PDR patients (12 men and 18 women) treated with PRP were included (mean age: 51 years, SD: 5,08 years). On average, patients received 1.264 laser spots. The National Eye Institute 7-Item Visual Function Index (VF-7) was used to evaluate patient's vision-related quality of life. The VF-7 was filled in by interview twice, at the beginning before laser PRP and at least 1 month after the completion of PRP. Comparison of VF-7 before and after laser PRP was performed. The correlation between alteration in visual acuity and VF-7 will be evaluated.
Results: Mean VF-7 before laser PRP was 7.00 ± 0.00 and after laser PRP it was 3.43 ± 3.16 (p<0.001, Wilcoxon). VF-7 scores had a statistically significant difference between before and after laser PRP (p<0.05). There was a strong correlation between VF-7 score alteration with visual acuity (p <0.001, r 0.748).
Conclusion: There was a significant improvement in vision-related quality of life following panretinal photocoagulation of patients with proliferative diabetic retinopathy.
Full text article
References
American academy of ophthalmology. Basic and clinical science course. Retina and vitreous. Section 8. 2016 – 2017. p. 134-137
Kementrian Kesehatan RI. Infodatin Diabetes. Pusat Data dan Informasi. Jakarta. 2014
Solomon S, Emily C, Elia J. Diabetic Retinopathy: A Position Statement by the America Diabetes Association. Diabetes Journals. March 2017. p.412-418
Cho N, Shaw J, Huang Y. IDF Diabetes Atlas: Global Estimates Of Diabetes Prevalence For 2017 and Projections For 2045. Diabetic Research and Clinical Practice. Melbourne. 2018. p. 271-281.
Ellia D, Aristidis V. Diabetic Retinopathy. Humana Press. United States, America. 2008. p 52-53
David A, Barbara A. Clinical Retina. American Medical Association. United States, America. 2002. p. 347
Datson M, Amish S. Quality of Life in People with Diabetic Retinopathy: Indian Study. Karnataka. Journal of Clinical and Diagnostic Research. 2017
Risto J, Tina B. Evaluating Cataract Surgery Gains By Assessing Patients’ Quality Of Life Using The VF-7. J Cataract Refract. Elsevier Science Inc. 2015.
Miltiadis K, Tsilimbaris A. Effect Of Panretinal Photocoagulation Treatment On Vision-Related Quality Of Life Of Patients With Proliferative Diabetic Retinopathy. Greece. NCBI. 2015. p. 756-761.
Sindhu NM, Padmavathi P. Vision Related Quality Of Life Following Panretinal Photocoagulation In Proliferative Diabetic Retinopathy. J.Evid. BasedMed.Healthc. 2018, p. 3098
Yorston D, Jalali S. Retinal detachment in developing countries. Eye. 2002;16(4):353-358.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.